1. Lewis Y antigen expression and postoperative survival in non–small cell lung cancer 
Fumihiro Tanaka, MD, Ryo Miyahara, MD, Yohsuke Ohtake, MD, Kazuhiro Yanagihara, MD, Tatsuo Fukuse, MD, Shigeki Hitomi, MD, Hiromi Wada, MD 
The Annals of Thoracic Surgery 
Volume 66, Issue 5, Pages (November 1998)
DOI: /S (98)

2. Fig 1
Survival after complete tumor resection with lymph node dissection for non–small cell lung cancer during 1985–1990 at Kyoto University. Comparison between that for Lewis Y antigen (LeYLeY) expression positive disease and that for LeY expression negative disease.
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

3. Fig 2
Survival after complete tumor resection with lymph node dissection for non–small cell lung cancer during 1985–1990 at Kyoto University. Comparison between that for Lewis Y antigen (LeY) expression positive disease and that for LeY expression negative disease.
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

4. Fig 3
Comparison of postoperative survival between LeY-positive and p53 aberrant expression negative disease (A), that for LeY-positive and p53 aberrant expression positive disease (B), that for LeY-negative and p53 aberrant expression negative disease (C), and that for LeY-negative and p53 aberrant expression positive disease (D).
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

5. Fig 4
Comparison of postoperative survival for p-stage 1, NSCLC between LeYpositive and p53 aberrant expression negative disease (A), that for LeY-positive and p53 aberrant expression positive disease (B), that for LeY-negative and p53 aberrant expression negative disease (C), and that for LeY-negative and p53 aberrant expression positive disease (D).
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

6. The Annals of Thoracic Surgery 1998 66, 1745-1750DOI: (10
The Annals of Thoracic Surgery  , DOI: ( /S (98) )